Você pesquisou por y - Revista Brasileira de Ginecologia e Obstetrícia
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2002;24(3):205-205
DOI 10.1590/S0100-72032002000300010
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2002;24(3):205-205
DOI 10.1590/S0100-72032002000300010
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2002;24(3):205-205
DOI 10.1590/S0100-72032002000300011
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2002;24(3):205-205
DOI 10.1590/S0100-72032002000300011
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(4):205-208
DOI 10.1590/S0100-72032001000400002
Purpose: to evaluate the rate of lymphedema and its relation to the type of surgery, age and weight of the patient. Methods: one hundred and nine patients with breast cancer, submitted to modified radical mastectomy sparing the pectoralis major or both pectorales, were studied. Differences of more than 2.0 cm between the diameters of the upper members, measured above and below the elbow, were considered as due to lymphedema. Results: a total rate of 14% of this complication was observed (15 cases). In mastectomies sparing both pectoralis muscles, a smaller rate was observed (9%), when compared to 15% using Patey's technique. However, the difference was not significant. There was a significant relationship between the incidence of lymphedema and the patient's weight and age. The lymphedema was observed in only one of the 34 patients younger than 46 years old, and none of the 19 patients with up to 50 kg presented lymphedema. Conclusion: in the present series lymphedema of the upper limb was associated with the older and heavier patients.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2001;23(4):205-208
DOI 10.1590/S0100-72032001000400002
Purpose: to evaluate the rate of lymphedema and its relation to the type of surgery, age and weight of the patient. Methods: one hundred and nine patients with breast cancer, submitted to modified radical mastectomy sparing the pectoralis major or both pectorales, were studied. Differences of more than 2.0 cm between the diameters of the upper members, measured above and below the elbow, were considered as due to lymphedema. Results: a total rate of 14% of this complication was observed (15 cases). In mastectomies sparing both pectoralis muscles, a smaller rate was observed (9%), when compared to 15% using Patey's technique. However, the difference was not significant. There was a significant relationship between the incidence of lymphedema and the patient's weight and age. The lymphedema was observed in only one of the 34 patients younger than 46 years old, and none of the 19 patients with up to 50 kg presented lymphedema. Conclusion: in the present series lymphedema of the upper limb was associated with the older and heavier patients.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2013;35(5):205-209
DOI 10.1590/S0100-72032013000500003
PURPOSE: To investigate the impact of pregnancy on female sexual function. METHODS: An analytical, cross-sectional study was conducted on 181 non-pregnant and 177 pregnant women aged 18 to 45 years. The study included premenopausal, sexually active women with a steady partner and excluded those taking antidepressants or with a diagnosis of depression. Eleven of these women (6.2%) were in the first trimester, 50 (28.2%), in the second trimester and 116 (65.5%), in the third trimester of pregnancy. The evaluation consisted of an interview in which the Female Sexual Function Index (FSFI) was applied. The data were analyzed using the Statistical Package for the Social Sciences (SPSS) software, version 16.0. The nonparametric Mann-Whitney test was used to compare the mean FSFI values of pregnant and non-pregnant women. RESULTS: Sexual dysfunction was 40.4% among pregnant women and 23.3% among non-pregnant women, with a significant difference between the scores of the studied groups (p=0.01). The difference in the mean global FSFI values between the groups was also significant (p<0.0001). There were significant differences between pregnant and non-pregnant women regarding desire (p<0.0001), excitation (p=0.003), lubrication (p=0.02), orgasm (p=0.005) and satisfaction (p=0.03). The same was not observed regarding pain. CONCLUSION: We conclude that pregnancy negatively influences female sexual function, particularly the desire and excitement domains, revealing the importance of addressing the issue by professionals dealing with pregnant women.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2013;35(5):205-209
DOI 10.1590/S0100-72032013000500003
PURPOSE: To investigate the impact of pregnancy on female sexual function. METHODS: An analytical, cross-sectional study was conducted on 181 non-pregnant and 177 pregnant women aged 18 to 45 years. The study included premenopausal, sexually active women with a steady partner and excluded those taking antidepressants or with a diagnosis of depression. Eleven of these women (6.2%) were in the first trimester, 50 (28.2%), in the second trimester and 116 (65.5%), in the third trimester of pregnancy. The evaluation consisted of an interview in which the Female Sexual Function Index (FSFI) was applied. The data were analyzed using the Statistical Package for the Social Sciences (SPSS) software, version 16.0. The nonparametric Mann-Whitney test was used to compare the mean FSFI values of pregnant and non-pregnant women. RESULTS: Sexual dysfunction was 40.4% among pregnant women and 23.3% among non-pregnant women, with a significant difference between the scores of the studied groups (p=0.01). The difference in the mean global FSFI values between the groups was also significant (p<0.0001). There were significant differences between pregnant and non-pregnant women regarding desire (p<0.0001), excitation (p=0.003), lubrication (p=0.02), orgasm (p=0.005) and satisfaction (p=0.03). The same was not observed regarding pain. CONCLUSION: We conclude that pregnancy negatively influences female sexual function, particularly the desire and excitement domains, revealing the importance of addressing the issue by professionals dealing with pregnant women.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2014;36(5):205-210
DOI 10.1590/S0100-7203201400050004
To investigate protein expression and mutations in phosphatase and tensin homolog (PTEN) in patients with stage IB cervical squamous cell carcinoma (CSCC) and the association with clinical-pathologic features, tumor p53 expression, cell proliferation and angiogenesis.
Women with stage IB CSCC (n=20 - Study Group) and uterine myoma (n=20 - Control Group), aged 49.1±1.7 years (mean±standard deviation, range 27-78 years), were prospectively evaluated. Patients with cervical cancer were submitted to Piver-Rutledge class III radical hysterectomy and pelvic lymphadenectomy and patients in the Control Group underwent vaginal hysterectomy. Tissue samples from the procedures were stained with hematoxylin and eosin for histological evaluation. Protein expression was detected by immunohistochemistry. Staining for PTEN, p53, Ki-67 and CD31 was evaluated. The intensity of PTEN immunostaining was estimated by computer-assisted image analysis, based on previously reported protocols. Data were analyzed using the Student's t-test to evaluate significant differences between the groups. Level of significance was set at p<0.05.
The PTEN expression intensity was lower in the CSCC group than in the Control (benign cervix) samples (150.5±5.2 versus 204.2±2.6; p<0.001). Our study did not identify any mutations after sequencing all nine PTEN exons. PTEN expression was not associated with tumor expression of p53 (p=0.9), CD31 (p=0.8) or Ki-67 (p=0.3) or clinical-pathologic features in patients with invasive carcinoma of the cervix.
Our findings demonstrate that the PTEN protein expression is significantly diminished in CSCC.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2014;36(5):205-210
DOI 10.1590/S0100-7203201400050004
To investigate protein expression and mutations in phosphatase and tensin homolog (PTEN) in patients with stage IB cervical squamous cell carcinoma (CSCC) and the association with clinical-pathologic features, tumor p53 expression, cell proliferation and angiogenesis.
Women with stage IB CSCC (n=20 - Study Group) and uterine myoma (n=20 - Control Group), aged 49.1±1.7 years (mean±standard deviation, range 27-78 years), were prospectively evaluated. Patients with cervical cancer were submitted to Piver-Rutledge class III radical hysterectomy and pelvic lymphadenectomy and patients in the Control Group underwent vaginal hysterectomy. Tissue samples from the procedures were stained with hematoxylin and eosin for histological evaluation. Protein expression was detected by immunohistochemistry. Staining for PTEN, p53, Ki-67 and CD31 was evaluated. The intensity of PTEN immunostaining was estimated by computer-assisted image analysis, based on previously reported protocols. Data were analyzed using the Student's t-test to evaluate significant differences between the groups. Level of significance was set at p<0.05.
The PTEN expression intensity was lower in the CSCC group than in the Control (benign cervix) samples (150.5±5.2 versus 204.2±2.6; p<0.001). Our study did not identify any mutations after sequencing all nine PTEN exons. PTEN expression was not associated with tumor expression of p53 (p=0.9), CD31 (p=0.8) or Ki-67 (p=0.3) or clinical-pathologic features in patients with invasive carcinoma of the cervix.
Our findings demonstrate that the PTEN protein expression is significantly diminished in CSCC.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2010;32(5):205-207
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2010;32(5):205-207
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):206-206
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):206-206
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):206-206
DOI 10.1590/S0100-72032006000300014
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):206-206
DOI 10.1590/S0100-72032006000300014